In some embodiments, the otic formulation or composition comprises about 5% by weight of the viscosity modulating agent(s)
How Payer Friction and Patient Drop-Off Undermine Obesity GLP-1 Uptake The GLP-1 market is experiencing unprecedented demand, yet despite its clinical promise for obesity, diabetes, and other conditions, patient behavior and friction throughout the treatment journey continue to erode its commercial potential
Glutathione is a tripeptidea combination of three amino acids called cysteine, glycine, and glutamine
So far, fewer than 1% of children and teenagers have taken GLP-1s, but that number is rising quickly
This well-studied application has made strides in the treatment of IR, serving as a new and upcoming innocuous supplement that, when coupled with subtle lifestyle changes, can ameliorate IR
[25] In a groundbreaking study, researchers found that berberine treatment restored GLP-1 secretion in diet-induced obese mice, not only reversing the decline in GLP-1 levels but actually increasing them above baseline compared to healthy controls